Literature DB >> 20652771

Clinical trials report: sumatriptan-naproxen combination for symptomatic treatment of comorbid dysmenorrhea and migraine.

E Anne MacGregor1.   

Abstract

Entities:  

Year:  2010        PMID： 20652771     DOI： 10.1007/s11916-010-0134-6

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN： 1534-3081


× No keyword cloud information.
  10 in total

1.  The International Classification of Headache Disorders: 2nd edition.

Authors: 
Journal:  Cephalalgia       Date:  2004       Impact factor: 6.292

Review 2.  Acute treatment and prevention of menstrually related migraine headache: evidence-based review.

Authors:  Tamara Pringsheim; William Jeptha Davenport; David Dodick
Journal:  Neurology       Date:  2008-04-22       Impact factor: 9.910

Review 3.  Meta-analysis of the efficacy and safety of naproxen sodium in the acute treatment of migraine.

Authors:  Chuthamanee C Suthisisang; Nalinee Poolsup; Naeti Suksomboon; Vorachart Lertpipopmetha; Bhakanit Tepwitukgid
Journal:  Headache       Date:  2010-03-05       Impact factor: 5.887

4.  Sumatriptan-naproxen for acute treatment of migraine: a randomized trial.

Authors:  Jan Lewis Brandes; David Kudrow; Stuart R Stark; C Phillip O'Carroll; James U Adelman; Francis J O'Donnell; W James Alexander; Susan E Spruill; Pamela S Barrett; Shelly E Lener
Journal:  JAMA       Date:  2007-04-04       Impact factor: 56.272

Review 5.  Oral sumatriptan for acute migraine.

Authors:  D C McCrory; R N Gray
Journal:  Cochrane Database Syst Rev       Date:  2003

6.  Prevalence of migraine on each day of the natural menstrual cycle.

Authors:  E Anne MacGregor; Allan Hackshaw
Journal:  Neurology       Date:  2004-07-27       Impact factor: 9.910

Review 7.  Nonsteroidal anti-inflammatory drugs for dysmenorrhoea.

Authors:  Jane Marjoribanks; Michelle Proctor; Cindy Farquhar; Roos S Derks
Journal:  Cochrane Database Syst Rev       Date:  2010-01-20

8.  Impact of migraine on patients and their families: the Migraine And Zolmitriptan Evaluation (MAZE) survey--Phase III.

Authors:  E A MacGregor; J Brandes; A Eikermann; R Giammarco
Journal:  Curr Med Res Opin       Date:  2004-07       Impact factor: 2.580

9.  Cumulative lifetime migraine incidence in women and men.

Authors:  W F Stewart; C Wood; M L Reed; J Roy; R B Lipton
Journal:  Cephalalgia       Date:  2008-07-15       Impact factor: 6.292

10.  Naproxen sodium in short-term prophylaxis of pure menstrual migraine: pathophysiological and clinical considerations.

Authors:  G Allais; G Bussone; C De Lorenzo; I Castagnoli Gabellari; M Zonca; O Mana; P Borgogno; G Acuto; C Benedetto
Journal:  Neurol Sci       Date:  2007-05       Impact factor: 3.307
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.